The CRM pre-earnings setup is the quietest one on the board. Our November 4 scan priced CRM at $231.47 and the session settled at $227.11, up 2.21% on the day, with the month at -1.17% and a December 2, 2026 print 28 days out.

The score is 85 at rank 17 of 82 rows. Salesforce is the second most covered name we carry at 56 analysts, and it is also the row with the most holds of anything scoring 80 or better: 15 of 56 analysts are sitting on the fence.

That is the setup. A company watched by nearly everyone and owned outright by nobody in particular, and an options market charging 10.5% over three days for the print.

The row, 28 days from the print

Score 85, rank 17, sector Technology, print date December 2, earnings sentiment Positive, short interest 3.9% of float, market capitalization $190.50 billion, implied volatility 53.4, and a scan price of $231.47.

Decomposed, the 85 is the full 25 points for analyst coverage, 17.9 points for a 71.4% buy-side share, 12 points for six strong buys, 14.8 points for a 14.8% five-day implied move, and the full 15 for a Positive sentiment reading.

Only two of those five columns are full, and the two that are short describe the street rather than the market. Conviction gives up 7.1 points because 71.4% is not a committed book, and the strong-buy column gives up 8 because six strong buys on 56 analysts is a thin ratio.

The market side is the opposite. The implied-move column gives up only 0.2 points and the sentiment column is maxed at 15, so the score is doing exactly what the table says: a wide, watchable book on a calm event.

When does CRM report earnings, and is it a buy before the print?

Salesforce reports on Wednesday December 2, 2026, and the case for buying before it is the case for buying a cheap event on a heavily watched name.

The verdict is a qualified yes, with one condition attached. A score of 85, 40 of 56 analysts on the buy side and a $247.34 target 6.9% above the scan price is a setup. The condition is that the options market charges 10.5% over three days for it, less than it charges for names with worse books.

What is in the room is an acquisition. The headline our scanner carries for CRM is a definitive agreement to acquire Cresta, and December 2 is the first report Salesforce files with that agreement in the background.

So the honest answer is this. If the acquisition goes into the numbers and the guide holds, a book of 56 analysts is wide enough to move on the print alone. If it costs more than the street expects, the 15 holds become the story rather than the 6 strong buys.

Why the book is wide and uncommitted

Coverage is the strongest column on the row. 56 analysts is the second most on the board behind NVDA's 62, and all 25 available points go to it.

Conviction is where it goes wrong. 40 of 56 ratings are on the buy side, which is 71.4%, against 88.6% on MRVL, 91.5% on DDOG and 95.2% on NVDA.

And 15 analysts are on hold, more than any other row scoring 80 or better. PANW has 12, ZS and CRWD have 11, and OKTA has 10.

The strong-buy column tells the same story. Six strong buys on 56 analysts is a 10.7% ratio, the thinnest of any row scoring 80 or better. AMAT is next at 12.2% on 41 analysts, and ZS is at 14.9%.

What that means for December 2 is that the street has reserved its judgment. The name is watched by more analysts than any other $190 billion company we carry, and more than one in four of them is sitting on hold.

How does CRM's implied move compare with the rest of the board?

It is among the cheapest events we carry, and it is the second quietest name on the December 2 calendar.

CRM's 10.5% three-day implied move and 53.4 implied volatility sit well below SNOW at 12.0% and 119.8, OKTA at 15.8% and 155.2, CRWD at 12.3% and 75.9, MDB at 14.2% and 87.9, and MRVL at 14.4% and 79.7.

Only 11 of the 82 rows we carry have a lower implied volatility than Salesforce, and on its own calendar CRM's 10.5% is second only to NCNO's 5.8%, ahead of PATH's 10.6% and SNOW's 12.0%.

That is a real signal and it cuts both ways. A cheap event is cheap to own. It is also the options market saying it does not expect Salesforce to reprice much on December 2.

What has to change for CRM to be a buy before the print?

The strong-buy count first, because it is 8 points of the score and it is the column the market has not settled.

Six strong buys is 12 of 20 points. Ten would be the full 20 and would put CRM on 93, level with OKTA and above CRWD, without a single new quarter being needed.

Second the conviction column, which is a function of the same thing. Moving 15 holds to buys is worth 6.7 points at a 25-point maximum.

Third the price, because the row names the levels. Our scan price is $231.47, the analyst target is $247.34 with 6.9% of room above it, and the downside mark on the row is $215.61, which is 6.9% below the scan price.

And one thing that is already working. The price has held. CRM is down 1.17% over the month and 6.20% over the week, and it closed at $227.11 on November 4 after touching $222.20 on November 3.

Our own scan ran at 6:30 Pacific time and every figure on this page comes from it, published in full at our open data.

So the CRM pre-earnings setup is a score of 85 built on coverage and sentiment rather than conviction, 28 days out from a print the options market prices at 10.5%. The target is $247.34, the downside mark is $215.61, and an acquisition is in the room. The reader decides whether the widest book on the board, carrying the most holds of any strong-scoring row, is a setup that has been priced or one that has been left alone.

Frequently asked questions about CRM

When does Salesforce report earnings?

Salesforce reports on Wednesday December 2, 2026, which is 28 days after our November 4 scan. SNOW, NCNO and PATH print the same day.

Is CRM a buy before the December 2 earnings report?

On the row, a qualified yes. A score of 85, 40 of 56 analysts on the buy side and a 10.5% implied move make it one of the cheaper events we carry, with the target at $247.34 and the downside mark at $215.61. The condition is the book itself: 15 analysts on hold and only 6 strong buys.

What is CRM's implied move and analyst target?

The options market prices a 10.5% move over three days, a band from $207.25 to $255.70 around our $231.47 scan price, and 14.8% over five days on 53.4 implied volatility. The analyst target is $247.34, 6.9% above the scan price.